12/02/2024 - 15:31

Heavy losses for CSL help drag ASX into the red

12/02/2024 - 15:31


Save articles for future reference.

The Australian share market has finished down 0.4 per cent in large part because of a failed heart attack drug that CSL spent nearly $1 billion developing.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options